158 related articles for article (PubMed ID: 14506024)
1. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.
Karlowsky JA; Jones ME; Draghi DC; Sahm DF
Antimicrob Agents Chemother; 2003 Oct; 47(10):3155-60. PubMed ID: 14506024
[TBL] [Abstract][Full Text] [Related]
2. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
5. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
Williams-Bouyer N; Hernandez A; Reisner BS
J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
[TBL] [Abstract][Full Text] [Related]
6. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
7. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
[TBL] [Abstract][Full Text] [Related]
8. Homology analysis of 51 penicillin-intermediate
Zhang J; Hu DK; Gao CY; Shen WW; Luo XH; Yu J; Li XY; Jiang XY; Zhu WS; Chen WQ
J Int Med Res; 2020 Jun; 48(6):300060520919061. PubMed ID: 32529912
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolated in central Taiwan.
Liu PY; Hu BS; Fung CP; Lau YJ; Shi ZY; Lin YH
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):511-5. PubMed ID: 9764388
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
Skulnick M; Small GW; Lo P; Patel MP; Porter CR; Low DE; Matsumura S; Mazzulli T
J Clin Microbiol; 1995 Sep; 33(9):2334-7. PubMed ID: 7494023
[TBL] [Abstract][Full Text] [Related]
11. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae.
Macias EA; Mason EO; Ocera HY; LaRocco MT
J Clin Microbiol; 1994 Feb; 32(2):430-2. PubMed ID: 8150953
[TBL] [Abstract][Full Text] [Related]
12. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Murphy ME; Powell E; Courter J; Mortensen JE
BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
[TBL] [Abstract][Full Text] [Related]
13. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
Thornsberry C; Burton PH; Vanderhoof BH
Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
Yenişehirli G; Sener B
Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
[TBL] [Abstract][Full Text] [Related]
17. Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America.
Castanheira M; Jones RN; Silbert S; Brandileone MC; Sader HS
Microb Drug Resist; 2003; 9(4):345-51. PubMed ID: 15000740
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
20. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
Esposito S; Noviello S; Ianniello F
Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
